From: Prognostic significance of MUC2, CDX2 and SOX2 in stage II colorectal cancer patients
 | CDX2 | MUC2 | SOX2 | ||||||
---|---|---|---|---|---|---|---|---|---|
Low | High | P | Low | High | P | – | + | P | |
Patients | 33 | 194 | 164 | 63 | 184 | 43 | |||
Age (years) | |||||||||
 Media | 67.7 ± 11.8 | 68.4 ± 11.4 | 0.81 | 68.3 ± 11.7 | 68.2 ± 11.1 | 0.96 | 67.9 ± 11.5 | 69.9 ± 11.1 | 0.74 |
 Range | 35–87 | 23–92 | 23–92 | 37–83 | 23–92 | 37–87 | |||
Sex | |||||||||
 Female | 19 | 73 | 0.04* | 65 | 27 | 0.65 | 72 | 20 | 0.39 |
 Male | 14 | 121 | 99 | 36 | 112 | 23 | |||
Histopathological grade (n = 224; ND = 3) | |||||||||
 G1 | 0 | 4 | < 0.001* | 1 | 3 | 0.05 | 3 | 1 | 0.20 |
 G2 | 25 | 185 | 157 | 53 | 173 | 37 | |||
 G3 | 7 | 3 | 6 | 4 | 6 | 4 | |||
Tumor Location (n = 224; ND = 3) | |||||||||
 Proximal colon | 16 | 59 | 0.09 | 48 | 27 | 0.13 | 58 | 17 | 0.22 |
 Distal colon | 14 | 93 | 83 | 24 | 92 | 15 | |||
 Rectum | 3 | 39 | 30 | 12 | 32 | 10 | |||
Mismatch repair status (n = 209; ND = 18) | |||||||||
 MMR-deficient | 22 | 69 | < 0.001* | 68 | 23 | 0.75 | 77 | 14 | 0.37 |
 MMR-proficient | 7 | 111 | 85 | 33 | 93 | 25 | |||
BRAFV600E (n = 216; ND = 11) | |||||||||
 WT | 25 | 161 | 0.17 | 132 | 54 | 1.00 | 152 | 34 | 0.80 |
 MUT | 7 | 23 | 21 | 9 | 24 | 6 | |||
CDX2 | |||||||||
 Low |  | 23 | 10 | 0.83 | 26 | 7 | 0.81 | ||
 High | 141 | 53 | 158 | 36 | |||||
MUC2 | |||||||||
 Low |  |  | 137 | 27 | 0.13 | ||||
 High | 47 | 16 |